Cross-linked fibrin degradation products, progression of peripheral arterial disease, and risk of coronary heart disease
- 1 July 1993
- journal article
- Published by Elsevier in The Lancet
- Vol. 342 (8863) , 84-86
- https://doi.org/10.1016/0140-6736(93)91288-w
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- A Six Year Prospective Study of Fibrinogen and Other Risk Factors Associated with Mortality in Stable ClaudicantsThrombosis and Haemostasis, 1992
- Antithrombin III and arterial diseaseThe Lancet, 1991
- Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies.Circulation, 1991
- Fate of fibrinogen in human arterial intima.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1990
- Variability of ankle and brachial systolic pressures in the measurement of atherosclerotic peripheral arterial disease.Journal of Epidemiology and Community Health, 1988
- PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTIONThe Lancet, 1987
- HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDYThe Lancet, 1986
- Fibrinogen as a Risk Factor for Stroke and Myocardial InfarctionNew England Journal of Medicine, 1984